Medical Technology Deals Double in Value as Cash Meets Demand
This article is for subscribers only.
Mergers and acquisitions by medical technology companies in the U.S. and Europe doubled in value to $30.6 billion last year from 2009, led by the industry’s biggest firms, according to an Ernst & Young LLP report.
More than $47.3 billion in transactions have been announced so far in 2011, led by Johnson & Johnson’s $21.3 billion proposed purchase of Synthes Inc., the report said. The number of acquisitions increased to 201 last year, from 171 in 2009, according to Ernst & Young.